In an increasingly complex pharma environment, successful go-to-market execution requires a clear commercial strategy, strong market prioritization, stakeholder alignment, and scalable launch models. Drawing on over 25 years of global commercial leadership across pharmaceuticals, radiopharmaceuticals, and medical devices, this session will explore how companies can translate market opportunities into sustainable growth. The talk will focus on practical approaches to market entry, launch planning, commercial excellence, market access, distributor models, and cross-functional execution across diverse international markets